The incomplete activation of CD96 downstream signaling cascades may also lead to tumor-promoting effects through activation of MAPK, NF-κB, and PI3K pathways, which contribute to cell proliferation, survival, and migration. The gene discussed is NFKB1; the disease is neoplasm.